BillRebuttal vs ArteraAI
A side-by-side comparison built from both listings. Blank cells mean the company has not given that detail; we never guess.
BillRebuttal compared with ArteraAI
| Detail |
BillRebuttal |
ArteraAI |
| What it does | Not given
| Personalized precision medicine powered by AI for cancer therapy
|
|---|
| Stage | Startup
| Not given
|
|---|
| Founded | 2026
| Not given
|
|---|
| Based in | US
| US
|
|---|
| Pricing model | Not given
| Contact for pricing
|
|---|
| Pricing | Free scan (no charge), Dispute Pack $19 one-time, Escalation Pack $39 one-time (USD). No subscription.
| Not given
|
|---|
| Key features | - Scan for duplicate charges and unbundling
- Compare prices to 2026 Medicare rates
- Check for No Surprises Act violations
- Estimate charity care eligibility
- Generate pre-filled dispute letters
- Collections debt validation letter
- Insurance appeal letter
- No account needed for free scan
- Bill not saved during free scan
- 14-day refund guarantee
| - Analyzes digital pathology with no additional tissue staining required
- Rapid results within 1-2 days after specimen receipt
- Validated across diverse populations including African American and non-African American men
- FDA De Novo authorization for prostate cancer risk stratification
- Insurance coverage for Medicare and many commercial plans
- Provides 5 and 10-year distant metastasis risk for breast cancer
- Identifies breast cancer patients who benefit from chemotherapy
- Included in NCCN Clinical Practice Guidelines for Prostate Cancer
|
|---|
| What makes it different | - Free scan with no account or signup required
- Fixed rules using public CMS data instead of AI model
- One-time pricing with no subscription or percentage of savings
| - No additional tissue preparation needed, uses existing H&E slides
- Validated across multiple large randomized phase III clinical trials
- FDA De Novo clearance as Software as a Medical Device
- Financial assistance program to make tests affordable regardless of income
|
| Community votes | 0 | 0 |
| DR (Domain Rating by Ahrefs) | 1 ● no change since last check | 57 ● no change since last check |
| Trust Flow (Majestic) | 1 | 15 |
| Citation Flow (Majestic) | 13 | 27 |
| Referring domains (Majestic) | 2 | 285 |
3 details filled in for both companies.
More alternatives to BillRebuttal More alternatives to ArteraAI